Industry
Happify Health and Almirall Partner Together to Launch Claro
Claro, a digital platform built to improve mental health for those with psoriasis who are living in Spain, the United
Friday, August 12, 2022
International Psoriasis Council
Advancing Knowledge. Enhancing Care.
Menu
Advancing Knowledge. Enhancing Care.
Menu
Category: Treatment
Congress Reports
Focus on Psoriasis: A Report from the 2022 Society for Investigative Dermatology (SID) Annual Meeting
The Society of Investigative Dermatology (SID) Annual Meeting returned to an in-person format in 2022 for the first time in
Friday, August 12, 2022
Industry
Lilly Announces a New, Citrate-Free Formulation of Taltz® (ixekizumab)
Eli Lilly announced a new formula for Taltz® that contains the same active ingredient as the original formulation, but patients
Wednesday, August 10, 2022
Industry
Arcutis Announces FDA Approval for ZORYVE (Roflumilast) Cream 0.3% for Plaque Psoriasis in Individuals Age 12 and Older
ZORYVE is the first and only topical phosphodiesterase-4 (PDE4) inhibitor approved to treat plaque psoriasis. The product is expected to
Tuesday, August 9, 2022
Expert Insights
Access to Biologics in Argentina: Rethinking Time to PASI 90
Biologics and biosimilars have created many new options in psoriasis treatment for patients worldwide, but patients worldwide face barriers to
Friday, July 1, 2022
Expert Insights
The Future of Treatment in Generalized Pustular Psoriasis
Recurrent flares, painful fiery-red skin, and sterile pustules — are the characteristics of Generalized Pustular Psoriasis (GPP), a rare and
Friday, July 1, 2022
Comorbidities
Exercise and Psoriasis: A Conversation with Dr. Helen Young
Patients with psoriasis are at increased risk for cardiovascular disease —and lack of physical activity may be a driving cause.
Tuesday, June 21, 2022
Expert Insights
Personalized Care in Psoriasis: A Conversation with Dr. Peter van de Kerkhof
Personalized care has become increasingly utilized in the past two few decades, evolving as we have gained a greater understanding
Monday, June 20, 2022
Expert Insights
How the Development of New Psoriasis Therapies May Change the Management of Tuberculosis
Psoriasis and tuberculosis have long gone hand-in-hand. This is especially true in certain parts of the world, where latent tuberculosis
Monday, June 20, 2022
Industry
Arcutis Biotherapeutics, Inc. Announced Findings From the Skin Insights: Uncovering Psoriasis Survey
Arcutis Biotherapeutics, Inc. shared their finding from the Skin Insights: Uncovering Psoriasis Survey.
Thursday, June 2, 2022